Anti-Infective Drugs Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Anti-Infective Drugs Market covers analysis By Type (RIDT, Viral Culture, DFA, Serological Assays); Application (Hospitals, Clinical Laboratories, Others), and geography, and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00021680
  • Category : Life Sciences
  • Status : Upcoming
  • No. of Pages : 150
Buy Now

MARKET INTRODUCTION



Anti-infective drugs are that work to prevent or treat infections. Antibiotics, antifungals, anthelmintics, antimalarials, antiprotozoals, antituberculosis agents, and antivirals are included in this category.

MARKET DYNAMICS



Factors driving the growth of the anti-infective drugs market are the growing prevalence of infectious diseases worldwide, coupled with rising research and development activities for the development of new drugs. However, the high cost of anti-infective drugs and poor reimbursement policies is expected to hamper the growth of the market. Moreover, increasing approvals for new anti-infective drugs in nutraceutical industries and growing awareness about infectious diseases among the population are anticipated to boost the market growth.

MARKET SCOPE



The "Anti-Infective Drugs Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of anti-infective drugs market with detailed market segmentation by drug type, route of administration, and indication. The anti-infective drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in anti-infective drugs market and offers key trends and opportunities in the market.

MARKET SEGMENTATION



The anti-infective drugs market is segmented on the basis of drug type, route of administration, and indication. Based on drug type, the market is segmented as antibiotics, antivirals, antifungals, and others. On the basis of route of administration, the market is categorized as HIV infections, pneumonia, hepatitis, herpes simplex virus, influenza, and others. On the basis of indication, the market is categorized as oral, topical, and others.

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the anti-infective drugs market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The anti-infective drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting anti-infective drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely, North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the anti-infective drugs market in these regions.

MARKET PLAYERS



The report covers key developments in the anti-infective drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from anti-infective drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for anti-infective drugs in the global market. Below mentioned is the list of few companies engaged in the anti-infective drugs market.

The report also includes the profiles of key players in anti-infective drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Merck & Co., Inc
  •   F. Hoffmann-La Roche Ltd
  •   Pfizer Inc
  •   Johnson & Johnson Services, Inc
  •   GlaxoSmithKline plc
  •   Hetero
  •   Mylan N.V.
  •   Aurobindo Pharma
  •   Cipla Inc
  •   Laurus Labs Ltd

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Anti-Infective Drugs Report Scope

Report Attribute Details
Market size in 2023 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Type
  • RIDT
  • Viral Culture
  • DFA
  • Serological Assays
By Application
  • Hospitals
  • Clinical Laboratories
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Merck & Co., Inc
  • F. Hoffmann-La Roche Ltd
  • Pfizer Inc
  • Johnson & Johnson Services, Inc
  • GlaxoSmithKline plc
  • Hetero
  • Mylan N.V.
  • Aurobindo Pharma
  • Cipla Inc
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    This text is related
    to segments covered.

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    This text is related
    to country scope.

    Trends and growth analysis reports related to Life Sciences : READ MORE..   

    The List of Companies

    1. Merck & Co., Inc
    2. F. Hoffmann-La Roche Ltd
    3. Pfizer Inc
    4. Johnson & Johnson Services, Inc
    5. GlaxoSmithKline plc
    6. Hetero
    7. Mylan N.V.
    8. Aurobindo Pharma
    9. Cipla Inc
    10. Laurus Labs Ltd
    11. Micro Labs Ltd, Inc
    12. Gilead Sciences, Inc
    13. Sun Pharmaceutical Industries Ltd
    14. Amneal Pharmaceuticals LLC
    15. Alembic Pharmaceuticals Limited
    16. Lupin
    17. Novartis AG
    18. Zydus Pharma
    19. Bausch Health

    Buy Now